previous post
SINdem4juniors report
next post
Societal Impact of Pain 2019 Report
You may also like
![](https://www.eanpages.org/wp-content/uploads/2020/06/yellow_EANcore_COVID-19_Visual_500x376px-10@2x-585x390.png)
Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection. The COVID A to Z randomized clinical trial
February 25, 2021![](https://www.eanpages.org/wp-content/uploads/2020/06/darkorange_EANcore_COVID-19_Visual_500x376px-10@2x-585x390.png)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
December 2, 2020![](https://www.eanpages.org/wp-content/uploads/2020/06/green_EANcore_COVID-19_Visual_500x376px-10@2x-585x390.png)
Myalgia as a symptom at hospital admission by SARS-CoV-2 infection is associated to persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study
May 5, 2021![](https://www.eanpages.org/wp-content/uploads/2020/06/grey_EANcore_COVID-19_Visual_500x376px-10@2x-585x390.png)